Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Hyperliquid Strategies Inc Common Stock (PURR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Hyperliquid Strategies Inc Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B), while Hyperliquid Strategies Inc Common Stock trades at $11.14 (market cap $2.24B). The key difference: Hyperliquid Strategies Inc Common Stock is the larger of the two by market cap, and Hyperliquid Strategies Inc Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Hyperliquid Strategies Inc Common Stock for 1 Days on average.
| NUVB | PURR | |
|---|---|---|
Market Cap | $1.74B | $2.24B |
Volume | 9,289,619 | 14,135,020 |
Sector | Health | Financials |
52-Week High | $9.54 | $14.09 |
52-Week Low | $3.41 | $3.10 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.33B | $2.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →
